Jaume Sauleda

13.0k total citations · 1 hit paper
102 papers, 5.0k citations indexed

About

Jaume Sauleda is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Jaume Sauleda has authored 102 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Pulmonary and Respiratory Medicine, 32 papers in Physiology and 15 papers in Epidemiology. Recurrent topics in Jaume Sauleda's work include Chronic Obstructive Pulmonary Disease (COPD) Research (49 papers), Respiratory Support and Mechanisms (27 papers) and Asthma and respiratory diseases (22 papers). Jaume Sauleda is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (49 papers), Respiratory Support and Mechanisms (27 papers) and Asthma and respiratory diseases (22 papers). Jaume Sauleda collaborates with scholars based in Spain, United Kingdom and France. Jaume Sauleda's co-authors include Àlvar Agustí, Jaime Pons, Xavier Busquets, Ernest Sala, Cristina Gómez, Bernat Togores, William MacNee, Judith García‐Aymerich, Bernardino Barceló Martín and Antònia Fuster and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Jaume Sauleda

100 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Systemic effects of chronic obstructive pulmonary disease

2003 773 citations Àlvar Agustí, Jaume Sauleda et al. European Respiratory Journal profile →

Peers

Countries citing papers authored by Jaume Sauleda

Since Specialization

Citations

This map shows the geographic impact of Jaume Sauleda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaume Sauleda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaume Sauleda more than expected).

Fields of papers citing papers by Jaume Sauleda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaume Sauleda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaume Sauleda. The network helps show where Jaume Sauleda may publish in the future.

Co-authorship network of co-authors of Jaume Sauleda

This figure shows the co-authorship network connecting the top 25 collaborators of Jaume Sauleda. A scholar is included among the top collaborators of Jaume Sauleda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaume Sauleda. Jaume Sauleda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pulmonary thrombosis associated with COVID‐19 pneumonia: Beyond classical pulmonary thromboembolism 2024 ·European Journal of Clinical Investigation ·(unknown), (unknown), (unknown), Núria Toledo-Pons, (unknown), (unknown), (unknown), Amanda Iglesias, Daniel Morell‐García, Josep Miquel Bauçà, Belén Núñez, Jaume Sauleda, Ernest Sala, Alberto Alonso‐Fernández	2
2	TLR/WNT: A Novel Relationship in Immunomodulation of Lung Cancer 2022 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Hanaa Shafiek, Antònia Obrador‐Hevia, Jaume Sauleda, Amanda Iglesias	14
3	Hsa-Mir-320c, Hsa-Mir-200c-3p, and Hsa-Mir-449c-5p as Potential Specific miRNA Biomarkers of COPD: A Pilot Study 2022 ·Pathophysiology ·(unknown), Amanda Iglesias, Hanaa Shafiek, (unknown), (unknown), Josep Muncunill, Aarne Fleischer, (unknown), Borja G. Cosío, Jaume Sauleda	8
4	Prevalence of pulmonary embolism in patients with COVID-19 pneumonia and high D-dimer values: A prospective study 2020 ·PLoS ONE ·Alberto Alonso‐Fernández, Núria Toledo-Pons, Borja G. Cosío, (unknown), (unknown), (unknown), (unknown), Daniel Morell‐García, Josep Miquel Bauçà, Belén Núñez, Jaume Pons, (unknown), (unknown), María Luz Pintos Peñaranda, (unknown), Jaume Sauleda, Ernest Sala	51
5	Prevalencia y percepción de la variabilidad diaria de los síntomas en pacientes con enfermedad pulmonar obstructiva crónica estable en España 2016 ·Archivos de Bronconeumología ·Juan José Soler‐Cataluña, Jaume Sauleda, Luís Valdés, (unknown), Ramón Agüero, Maite Pérez, Marc Miravitlles	21
6	B Cell–Activating Factor. An Orchestrator of Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease 2015 ·American Journal of Respiratory and Critical Care Medicine ·Francesca Polverino, Borja G. Cosío, Jaime Pons, María Laucho-Contreras, Paula Tejera, Amanda Iglesias, Ángel Ríos, Andreas Jahn, Jaume Sauleda, Miguel Divo, Víctor Pinto-Plata, Lynette M. Sholl, Iván O. Rosas, Àlvar Agustí, Bartolomé R. Celli, Caroline A. Owen	83
7	Late-breaking abstract: BAFF: A self-perpetuating mechanism of B cell activation in COPD 2014 ·European Respiratory Journal ·Francesca Polverino, Jaime Pons, Amanda Iglesias, Ángel Ríos, (unknown), Catalina Crespı́, Jaume Sauleda, Caroline A. Owen, Bartolomé R. Celli, Àlvar Agustí, Borja G. Cosío	2
8	Determinants of exercise capacity in obese and non-obese COPD patients 2014 ·Respiratory Medicine ·Diego A. Rodríguez, Judith García‐Aymerich, José Luis Valera, Jaume Sauleda, Bernat Togores, Juan B. Gáldiz, Joaquim Gea, Mauricio Orozco‐Levi, Antoni Ferrer, Federico P. Gómez, Joan Albert Barberà, Ignasi Serra, Josep M. Antó, Josep Roca	24
9	Air pollution and biomarkers of systemic inflammation and tissue repair in COPD patients 2014 ·European Respiratory Journal ·Payam Dadvand, Mark Nieuwenhuijsen, Àlvar Agustí, Jordi de Batlle, Marta Benet, Rob Beelen, Marta Cirach, David Martínez, Gerard Hoek, Xavier Basagaña, Antoni Ferrer, Jaume Ferrer, Robert Rodriguez-Roisín, Jaume Sauleda, Stefano Guerra, Josep M. Antó, (unknown)	98
10	Expression of HLA-DR in circulating polymorphonuclear neutrophils of COPD patients 2013 ·European Respiratory Journal ·(unknown), Jaume Pons, Borja G. Cosío, Àlvar Agustí, Andreas Jahn, Rocío Córdova, Jaume Sauleda	1
11	Role of C reactive protein in non small cell lung cancer staging 2011 ·European Respiratory Journal ·(unknown), (unknown), Jaume Sauleda, (unknown), Aina Noguera, Amanda Iglesias, Ángel Ríos, Rocío Córdova, Àlvar Agustí	2
12	Anti-Tissue Antibodies Are Related to Lung Function in Chronic Obstructive Pulmonary Disease 2010 ·American Journal of Respiratory and Critical Care Medicine ·Belén Núñez, Jaume Sauleda, Josep M. Antó, María Rosa Juliá, (unknown), Eduard Monsó, Aina Noguera, Federico P. Gómez, Judith García‐Aymerich, Àlvar Agustí	76
13	Variability and effects of bronchial colonisation in patients with moderate COPD 2009 ·European Respiratory Journal ·Alicia Marín, Eduard Monsó, Marian García-Núñez, Jaume Sauleda, (unknown), Jaime Pons, Àlvar Agustí, J. Morera	65
14	Systemic inflammation after inspiratory loading in chronic obstructive pulmonary disease 2008 ·SHILAP Revista de lepidopterología ·Antònia Fuster, Jaume Sauleda, Ernest Sala, (unknown), Jaume Pons, et al, (unknown), (unknown), (unknown)	2
15	Diagnóstico y guía terapéutica del paciente con taponamiento cardíaco o constricción pericárdica 2003 ·Revista Española de Cardiología ·Jaume Sauleda	14
16	Skeletal Muscle Apoptosis and Weight Loss in Chronic Obstructive Pulmonary Disease 2002 ·American Journal of Respiratory and Critical Care Medicine ·Àlvar Agustí, Jaume Sauleda, Cristina Miralles, Cristina Gómez, Bernat Togores, Ernest Sala, (unknown), Xavier Busquets	267
17	The Activity of Cytochrome Oxidase Is Increased in Circulating Lymphocytes of Patients with Chronic Obstructive Pulmonary Disease, Asthma, and Chronic Arthritis 2000 ·American Journal of Respiratory and Critical Care Medicine ·Jaume Sauleda, Francisco García-Palmer, Germán E. Gónzalez, Andreu Palou, Àlvar Agustí	52
18	Patients with Obstructive Sleep Apnea Exhibit Genioglossus Dysfunction that Is Normalized after Treatment with Continuous Positive Airway Pressure 1999 ·American Journal of Respiratory and Critical Care Medicine ·Miguel Carrera, Ferrán Barbé, Jaume Sauleda, (unknown), Cristina Gómez, Àlvar Agustí	130
19	Expression of Adhesion Molecules and G Proteins in Circulating Neutrophils in Chronic Obstructive Pulmonary Disease 1998 ·American Journal of Respiratory and Critical Care Medicine ·Aina Noguera, Xavier Busquets, Jaume Sauleda, (unknown), William MacNee, Àlvar Agustí	119
20	Cytochrome Oxidase Activity and Mitochondrial Gene Expression in Skeletal Muscle of Patients with Chronic Obstructive Pulmonary Disease 1998 ·American Journal of Respiratory and Critical Care Medicine ·Jaume Sauleda, Francisco García-Palmer, Rudolf J. Wiesner, (unknown), Inga Harting, (unknown), Cristina Gómez, Carles Saus, Andreu Palou, Àlvar Agustí	117

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact